RNU6-419P

Across TCGA pan-cancer cohorts, RNU6-419P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-419P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-419P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-419P expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUSC show a favorable association.

LIHC, KICH, and TGCT are the cancer types where RNU6-419P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.408	0.702	<.001	87	view →
KICH	DFS	Tertile	II,III,IV	0.077	0.851	<.001	66	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	24	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
UVM	DFS	Tertile	III,IV	0.079	0.674	.020	18	view →
ESCA	DFS	Median	II,III,IV	1.000	0.388	.010	18	view →
COAD	DFS	Tertile	III,IV	0.135	0.616	.019	18	view →
GBM	DFS	Tertile	All	0.150	0.305	.040	9	view →
LUSC	DFS	Tertile	III,IV	0.646	0.264	.024	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
SKCM	OS	Tertile	All	1.000	0.762	.027	6	view →
BLCA	OS	Tertile	III,IV	0.796	0.552	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-419P–LIHC (OS)

Open the LIHC breakdown →